Several Emerging Medtech Companies in the Spotlight on May 15, 2009, Hosted by Life Science Intelligence (LSI).HUNTINGTON BEACH, Calif. -- Life Science Intelligence (LSI LSI: see integrated circuit.(Large Scale Integration) Between 3,000 and 100,000 transistors on a chip. See SSI, MSI, VLSI and ULSI. ) announced today that several early stage medical technology companies representing a wide variety of product markets will be showcased at their upcoming Emerging Medical Technologies (EMT See Efficient markets theory. ) Spotlight - a virtual event being held on May 15, 2009 at 11 a.m. EST EST electroshock therapy. EST abbr. electroshock therapy . The program will feature select privately held companies with disruptive or emerging technologies competing for important medical device segments, including the $1 billion global small joint implant market and the $3 billion global breast disease detection and diagnostic market. More areas to be addressed include percutaneous heart valve replacement Heart Valve Replacement Definition Heart valve replacement is a surgical procedure during which surgeons remove a damaged valve from the heart and substitute a healthy one. , natural orifice orifice /or·i·fice/ (or´i-fis) 1. the entrance or outlet of any body cavity. 2. any opening or meatus.orific´ial aortic orifice translumenal endoscopic en·do·scope n. An instrument for examining visually the interior of a bodily canal or a hollow organ such as the colon, bladder, or stomach. en surgery (NOTES), and pulmonary disease, among others. The Emerging Medical Technologies (EMT) Spotlight is an online event that serves as a forum for medical technology innovators, investors and deal-makers to connect and collaborate. Registered attendees and select LSI members - which includes the top deal-making companies and venture capital firms Name Location Founding date Managing Partners/Directors Specialty Capital managed 5AM Ventures Menlo Park, CA; Waltham, MA 2002 John Diekman, PhD (managing partner), Scott Rocklage, PhD (managing partner), Andrew Schwab (managing partner) life sciences $200M [1] - will have an opportunity to quickly and efficiently preview innovative companies and then selectively network using LSI's proprietary and confidential online platform. All of the companies being featured on May 15th are raising venture capital or seeking partnerships and licensing deals with larger medtech companies. "During these tough economic times, it is more important than ever to be as productive as possible, while keeping expenses down. This venue helps the medtech community do so," says LSI's President Scott Pantel. This event provides early stage medical device company CEOs with a platform to efficiently share their business development and investment opportunities. Companies currently on the program include: Agendia, CardiAQ Valve Technologies, Insightra Medical, MedInvent, MiMedx, NeoMatrix, Nicast, Novian Health, Tomophase, Uptake Medical, and VIDA VIDA Voluntad Independiente de Anzoátegui (Venezuela political party) VIDA Voice Interoperability, Data and Access VIDA Volumetric Imaging Display and Analysis Diagnostics. To register to attend online from anywhere in the world or for additional details, visit www.emtspotlight.com. About Life Science Intelligence (LSI)[R] LSI delivers high-quality market data and competitive intelligence to medical technology executives, entrepreneurs, and investors. LSI produces the EMT (Emerging Medical Technologies)[R] Spotlight and Database, medtech market reports, and provides global custom research services. www.LSintelligence.com |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion